8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
暂无分享,去创建一个
S. Bruin | H. Tinteren | H. Boot | V. Verwaal | G. Slooten
[1] E. Van Cutsem,et al. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] F. Zoetmulder,et al. Learning curve of combined modality treatment in peritoneal surface disease , 2007, The British journal of surgery.
[3] L. Oñate-Ocaña,et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. , 2007, Annals of surgical oncology.
[4] C. Köhne,et al. Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. , 2007, Cancer treatment and research.
[5] P. Kam,et al. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[6] L. Oñate-Ocaña,et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement , 2006, Annals of Surgical Oncology.
[7] H. Boot,et al. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] P. Sugarbaker. A curative approach to peritoneal carcinomatosis from colorectal cancer. , 2005, Seminars in oncology.
[9] P. Sugarbaker. Re: Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy. J Surg Oncol 2004; 85:61–67 , 2004, Journal of surgical oncology.
[10] F. Kwiatkowski,et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[12] H. van Tinteren,et al. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy , 2004, The British journal of surgery.
[13] A. Witkamp,et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement , 2004, Journal of surgical oncology.
[14] H. Tinteren,et al. Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy , 2004, Journal of surgical oncology.
[15] A. Witkamp,et al. Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin , 2004, Annals of Surgical Oncology.
[16] H. van Tinteren,et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] F. Gilly,et al. Natural history of peritoneal carcinomatosis from nongynecologic malignancies. , 2003, Surgical oncology clinics of North America.
[18] P. Sugarbaker. Peritonectomy Procedures , 1995, Surgical oncology clinics of North America.
[19] R. Goldberg,et al. Review article: colorectal cancer chemotherapy. , 2003, Alimentary pharmacology & therapeutics.
[20] D. Jayne,et al. Peritoneal carcinomatosis from colorectal cancer , 2002, The British journal of surgery.
[21] A. Witkamp,et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. , 2001, Cancer treatment reviews.
[22] V. Eder,et al. The value of immunoscintigraphy in the detection of recurrent colorectal cancer , 2001, Nuclear medicine communications.
[23] C. Wilson,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] J. Faure,et al. Peritoneal carcinomatosis from non‐gynecologic malignancies , 2000, Cancer.
[25] P. Sugarbaker. Management of peritoneal-surface malignancy: the surgeon’s role , 1999, Langenbeck's Archives of Surgery.
[26] S. Devesa,et al. Incidence of colorectal carcinoma in the U.S. , 1999, Cancer.
[27] P. Sugarbaker. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis , 1994, Diseases of the colon and rectum.
[28] J. Spratt,et al. Hyperthermic peritoneal perfusion system in canines. , 1980, Cancer research.